{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:55:10Z","timestamp":1789779310976,"version":"4.0.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.intimp.2019.04.023","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T13:40:49Z","timestamp":1555422049000},"page":"258-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The skeletal renin-angiotensin system: A potential therapeutic target for the treatment of osteoarticular diseases"],"prefix":"10.1016","volume":"72","author":[{"given":"Jingjing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.04.023_bb0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1152\/physrev.1977.57.2.313","article-title":"Renin-angiotensin system: biochemistry and mechanisms of action","volume":"57","author":"Peach","year":"1977","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2019.04.023_bb0010","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/j.2040-4603.2014.tb00567.x","article-title":"Classical Renin-Angiotensin system in kidney physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0015","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-011-2398-8","article-title":"Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis","volume":"55","author":"Vejakama","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2019.04.023_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/CS20120030","article-title":"Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options","volume":"123","author":"Grace","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.intimp.2019.04.023_bb0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2019.04.023_bb0035","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2019.04.023_bb0040","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2019.04.023_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/147323001204000102","article-title":"Angiotensin receptor blockers in clinical practice\u2014implications of the ONTARGET study","volume":"40","author":"Jarvis","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.intimp.2019.04.023_bb0050","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2007.01.017","article-title":"AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers","volume":"46","author":"Debernardi-Venon","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0055","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.3748\/wjg.v11.i48.7560","article-title":"Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study","volume":"11","author":"Sookoian","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0060","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/jhep.2002.32679","article-title":"Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C","volume":"36","author":"Terui","year":"2002","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.intimp.2019.04.023_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00535-004-1523-6","article-title":"Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C","volume":"40","author":"Yoshiji","year":"2005","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2013.11.002","article-title":"The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease","volume":"142","author":"Giese","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2019.04.023_bb0075","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1096\/fj.07-098954","article-title":"Angiotensin II accelerates osteoporosis by activating osteoclasts","volume":"22","author":"Shimizu","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2019.04.023_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/932691","article-title":"Potential of RAS inhibition to improve metabolic bone disorders","volume":"2013","author":"Gebru","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2019.04.023_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.1520005","article-title":"Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro","volume":"152","author":"Hatton","year":"1997","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0090","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1074\/jbc.M807610200","article-title":"Angiotensin II type 2 receptor blockade increases bone mass","volume":"284","author":"Izu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2019.04.023_bb0095","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/00004872-200412000-00003","article-title":"Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system","volume":"22","author":"Kurtz","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.intimp.2019.04.023_bb0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/bbrc.1996.5914","article-title":"Angiotensin II stimulates the proliferation of osteoblast-rich populations of cells from rat calvariae","volume":"230","author":"Hiruma","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2019.04.023_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1677\/joe.0.1560543","article-title":"Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells","volume":"156","author":"Hagiwara","year":"1998","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0110","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/rheumatology\/kem092","article-title":"Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-kappaB pathway","volume":"46","author":"Pattacini","year":"2007","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.intimp.2019.04.023_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/648537","article-title":"Expression of angiotensin II receptor-1 in human articular chondrocytes","volume":"2012","author":"Kawakami","year":"2012","journal-title":"Arthritis"},{"key":"10.1016\/j.intimp.2019.04.023_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00467-003-1361-4","article-title":"Angiotensin II reduces calcium uptake into bone","volume":"19","author":"Schurman","year":"2004","journal-title":"Pediatr. Nephrol. (Berlin, Germany)"},{"key":"10.1016\/j.intimp.2019.04.023_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2017.04.031","article-title":"The ACE-2\/Ang1-7\/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor blockade","volume":"807","author":"Abuohashish","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0130","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41598-017-02570-x","article-title":"Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2\/Mas receptor axis","volume":"7","author":"Abuohashish","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2019.04.023_bb0135","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3892\/etm.2017.4404","article-title":"Effects of 1,25-dihydroxyvitamin D3 on the local bone renin-angiotensin system in a murine model of glucocorticoid-induced osteoporosis","volume":"13","author":"Shen","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2019.04.023_bb0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1359\/jbmr.081006","article-title":"Activation of renin-angiotensin system induces osteoporosis independently of hypertension","volume":"24","author":"Asaba","year":"2009","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.intimp.2019.04.023_bb0145","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1271\/bbb.120123","article-title":"Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice","volume":"76","author":"Gu","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.intimp.2019.04.023_bb0150","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12020-014-0196-z","article-title":"Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis","volume":"47","author":"Yongtao","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.intimp.2019.04.023_bb0155","first-page":"988","article-title":"Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems","volume":"75","author":"Grant","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2019.04.023_bb0160","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00198-014-2992-y","article-title":"Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients","volume":"26","author":"Shuai","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.intimp.2019.04.023_bb0165","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/jbmr.501","article-title":"Physiological function of the angiotensin AT1a receptor in bone remodeling","volume":"26","author":"Kaneko","year":"2011","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.intimp.2019.04.023_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MED.0000000000000062","article-title":"Interactions between adrenal-regulatory and calcium-regulatory hormones in human health","volume":"21","author":"Brown","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.intimp.2019.04.023_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00198-005-2035-9","article-title":"The role of collagen in bone strength","volume":"17","author":"Viguet-Carrin","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.intimp.2019.04.023_bb0180","article-title":"Contributions of the insulin\/insulin-like growth factor-1 axis to diabetic osteopathy","volume":"1","author":"Fowlkes","year":"2011","journal-title":"J. Diabetes Metab."},{"key":"10.1016\/j.intimp.2019.04.023_bb0185","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrrheum.2012.120","article-title":"Osteoporosis\u2014a risk factor for cardiovascular disease?","volume":"8","author":"Lampropoulos","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cytogfr.2012.06.003","article-title":"The \u201cbone morphogenic proteins\u201d pathways in bone and joint diseases: translational perspectives from physiopathology to therapeutic targets","volume":"24","author":"Biver","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2019.04.023_bb0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1074248413501018","article-title":"Renin-angiotensin system blocking drugs","volume":"19","author":"Robles","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2019.04.023_bb0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2014.00023","article-title":"Tissue Renin-Angiotensin systems: a unifying hypothesis of metabolic disease","volume":"5","author":"Skov","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0205","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10654-017-0285-4","article-title":"Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies","volume":"32","author":"Kunutsor","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0210","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/hr.2009.99","article-title":"Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats","volume":"32","author":"Shimizu","year":"2009","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.intimp.2019.04.023_bb0215","doi-asserted-by":"crossref","first-page":"e0122691","DOI":"10.1371\/journal.pone.0122691","article-title":"Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients","volume":"10","author":"Yamamoto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.04.023_bb0220","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","article-title":"Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese","volume":"38","author":"Lynn","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2019.04.023_bb0225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0895-7061(03)00845-8","article-title":"Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms","volume":"16","author":"Perez-Castrillon","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.intimp.2019.04.023_bb0230","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","article-title":"Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study","volume":"24","author":"Rejnmark","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.intimp.2019.04.023_bb0235","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1734-1140(12)70882-4","article-title":"Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs","volume":"64","author":"Donmez","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2019.04.023_bb0240","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3346\/jkms.2013.28.8.1139","article-title":"The effects of antihypertensive drugs on bone mineral density in ovariectomized mice","volume":"28","author":"Kang","year":"2013","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.intimp.2019.04.023_bb0245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00774-016-0748-9","article-title":"Effects of losartan treatment on the physicochemical properties of diabetic rat bone","volume":"35","author":"Donmez","year":"2017","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.intimp.2019.04.023_bb0250","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1248\/bpb.b14-00576","article-title":"Renin inhibition improves ovariectomy-induced osteoporosis of lumbar vertebra in mice","volume":"37","author":"Zhang","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2019.04.023_bb0255","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00198-015-3348-y","article-title":"Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice","volume":"27","author":"Zhang","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.intimp.2019.04.023_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00774-010-0209-9","article-title":"Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts","volume":"29","author":"Liu","year":"2011","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.intimp.2019.04.023_bb0265","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12020-014-0167-4","article-title":"Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis","volume":"46","author":"Ghosh","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.intimp.2019.04.023_bb0270","first-page":"613","article-title":"Plasma renin activity as a marker of renovascular injury in patients with rheumatoid arthritis","volume":"14","author":"Mavrikakis","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0275","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.49.7.517","article-title":"Raised plasma renin and prorenin in rheumatoid vasculitis","volume":"49","author":"Boers","year":"1990","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2019.04.023_bb0280","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1507\/endocrj1954.39.259","article-title":"Prorenin-renin axis in synovial fluid in patients with rheumatoid arthritis and osteoarthritis","volume":"39","author":"Izai","year":"1992","journal-title":"Endocrinol. Jpn."},{"key":"10.1016\/j.intimp.2019.04.023_bb0285","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1476-5381.1994.tb13091.x","article-title":"AT1 receptor characteristics of angiotensin analogue binding in human synovium","volume":"112","author":"Walsh","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0290","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.22335","article-title":"Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis","volume":"56","author":"Price","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2019.04.023_bb0295","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/ard.59.2.125","article-title":"Angiotensin converting enzyme in human synovium: increased stromal [(125) I]351A binding in rheumatoid arthritis","volume":"59","author":"Walsh","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2019.04.023_bb0300","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.51.4.476","article-title":"Production of angiotensin converting enzyme by rheumatoid synovial membrane","volume":"51","author":"Veale","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2019.04.023_bb0305","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/ard.45.11.921","article-title":"Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis","volume":"45","author":"Lowe","year":"1986","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2019.04.023_bb0310","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000196559","article-title":"Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis","volume":"63","author":"Soderblom","year":"1996","journal-title":"Respiration"},{"key":"10.1016\/j.intimp.2019.04.023_bb0315","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","article-title":"Proinflammatory actions of angiotensins","volume":"10","author":"Ruiz-Ortega","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.intimp.2019.04.023_bb0320","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0325","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0022-2828(03)00210-4","article-title":"Regulation of the human tumor necrosis factor-alpha promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors","volume":"35","author":"Sato","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0330","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1096\/fj.03-0129com","article-title":"Differential regulation of in vivo angiogenesis by angiotensin II receptors","volume":"17","author":"Walther","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2019.04.023_bb0335","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10787-017-0344-1","article-title":"Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin-angiotensin system in experimental arthritis","volume":"25","author":"Asghar","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2019.04.023_bb0340","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.27384","article-title":"Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers","volume":"62","author":"Sakuta","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2019.04.023_bb0345","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/hr.2015.18","article-title":"Continuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse","volume":"38","author":"Kawahata","year":"2015","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.intimp.2019.04.023_bb0350","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00296-004-0564-8","article-title":"Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis","volume":"25","author":"Cobankara","year":"2005","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.intimp.2019.04.023_bb0355","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(84)91821-X","article-title":"Captopril: a new treatment for rheumatoid arthritis?","volume":"1","author":"Martin","year":"1984","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.intimp.2019.04.023_bb0360","first-page":"603","article-title":"A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis","volume":"17","author":"Bird","year":"1990","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0365","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2019.04.023_bb0370","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jacc.2004.11.006","article-title":"Simvastatin improves endothelial function in patients with rheumatoid arthritis","volume":"45","author":"Hermann","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0375","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.ATV.0000033516.73864.4E","article-title":"Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis","volume":"22","author":"Bergholm","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0380","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.autrev.2003.10.006","article-title":"Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles","volume":"3","author":"Gonzalez-Gay","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2019.04.023_bb0385","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9150(03)00281-8","article-title":"Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity","volume":"170","author":"Hansel","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2019.04.023_bb0390","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2019.04.023_bb0395","first-page":"2095","article-title":"Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis","volume":"32","author":"Tikiz","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0400","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.107.734384","article-title":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis","volume":"117","author":"Flammer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2019.04.023_bb0405","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A tale of two diseases: atherosclerosis and rheumatoid arthritis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2019.04.023_bb0410","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1172\/JCI22651","article-title":"The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis","volume":"114","author":"Firestein","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2019.04.023_bb0415","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000354461","article-title":"Angiotensin II induces C-reactive protein expression via AT1-ROS-MAPK-NF-kappaB signal pathway in hepatocytes","volume":"32","author":"Zhao","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2019.04.023_bb0420","doi-asserted-by":"crossref","first-page":"G642","DOI":"10.1152\/ajpgi.00037.2003","article-title":"Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver","volume":"285","author":"Bataller","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0425","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/npp.2010.225","article-title":"Angiotensin II AT1 receptor blockade ameliorates brain inflammation","volume":"36","author":"Benicky","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.intimp.2019.04.023_bb0430","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.yexcr.2017.08.030","article-title":"Inhibition of angiotension II type 1 receptor reduced human endothelial inflammation induced by low shear stress","volume":"360","author":"Chao","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2019.04.023_bb0435","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/ard.2007.082917","article-title":"Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis","volume":"67","author":"Perry","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2019.04.023_bb0440","first-page":"1605","article-title":"Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat","volume":"36","author":"Caspritz","year":"1986","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.intimp.2019.04.023_bb0445","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/taap.2000.8985","article-title":"Effects of captopril on interleukin-6, leukotriene B (4), and oxidative stress markers in serum and inflammatory exudate of arthritic rats: evidence of antiinflammatory activity","volume":"168","author":"Agha","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0450","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/rheumatology\/keh398","article-title":"The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis","volume":"44","author":"Dalbeth","year":"2005","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.intimp.2019.04.023_bb0455","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejphar.2015.08.026","article-title":"Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats","volume":"765","author":"Fahmy Wahba","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0460","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/art.21040","article-title":"Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice","volume":"52","author":"Sagawa","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2019.04.023_bb0465","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","article-title":"Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis","volume":"46","author":"Silveira","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2019.04.023_bb0470","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejphar.2012.10.024","article-title":"Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats","volume":"698","author":"Refaat","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0475","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jcmm.12128","article-title":"Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis","volume":"17","author":"Wang","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2019.04.023_bb0480","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1476-5381.2010.00651.x","article-title":"Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation - role of a local renin-angiotensin system","volume":"159","author":"Garcia","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.023_bb0485","doi-asserted-by":"crossref","first-page":"e33228","DOI":"10.1371\/journal.pone.0033228","article-title":"Locally administrated perindopril improves healing in an ovariectomized rat tibial osteotomy model","volume":"7","author":"Zhao","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2019.04.023_bb0490","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.25011\/cim.v38i4.24261","article-title":"The effects of the angiotensin converting enzyme inhibitor enalapril and the angiotensin II type 1 receptor blocker losartan on fracture healing in rats","volume":"38","author":"Bayar","year":"2015","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.intimp.2019.04.023_bb0495","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","article-title":"Risk of fractures in older adults using antihypertensive medications","volume":"26","author":"Solomon","year":"2011","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.intimp.2019.04.023_bb0500","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/325693","article-title":"Comparative evaluation of enalapril and losartan in pharmacological correction of experimental osteoporosis and fractures of its background","volume":"2013","author":"Rajkumar","year":"2013","journal-title":"J. Osteoporos."},{"key":"10.1016\/j.intimp.2019.04.023_bb0505","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3892\/mmr.2014.1978","article-title":"Role of the local bone reninangiotensin system in steroidinduced osteonecrosis in rabbits","volume":"9","author":"Zhang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2019.04.023_bb0510","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1440-1797.2012.01656.x","article-title":"Early molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in mice","volume":"17","author":"Gu","year":"2012","journal-title":"Nephrology (Carlton, Vic)"},{"key":"10.1016\/j.intimp.2019.04.023_bb0515","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00774-013-0500-7","article-title":"Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes","volume":"32","author":"Diao","year":"2014","journal-title":"J. Bone Miner. Metab."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919302140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919302140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:15:09Z","timestamp":1761585309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919302140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":103,"alternative-id":["S1567576919302140"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.04.023","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The skeletal renin-angiotensin system: A potential therapeutic target for the treatment of osteoarticular diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}